|
|
|
Insider
Information: |
Andreotti Lamberto |
Relationship: |
|
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,011,868 |
|
Indirect Shares
|
241,273 |
|
|
Direct
Value |
$43,876,119 |
|
|
Indirect Value
|
$10,642,552 |
|
|
Total
Shares |
1,253,141 |
|
|
Total
Value |
$54,518,671 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
14.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
Director |
2017-04-07 |
935,571 |
2017-04-07 |
241,273 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-12-23 |
19,609 |
2009-02-17 |
0 |
Premium* |
|
DuPont de Nemours Inc |
DD |
Director |
2017-08-31 |
0 |
2012-08-02 |
0 |
Premium* |
|
Dowdupont Inc. |
DWDP |
Director |
2019-05-21 |
22,231 |
|
0 |
Premium* |
|
Corteva, Inc. |
CTVA |
|
2024-04-26 |
34,457 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
218 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-01 |
4/A |
D |
$25.58 |
$1,497,709 |
D/D |
(58,550) |
253,539 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2006-06-30 |
4 |
D |
$25.77 |
$34,171 |
D/D |
(1,326) |
264,653 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP & President, International |
|
2005-05-02 |
4 |
D |
$26.10 |
$46,171 |
D/D |
(1,769) |
110,709 |
|
- |
|
CTVA |
Corteva, Inc. |
Director |
|
2020-04-28 |
4 |
A |
$26.19 |
$170,235 |
D/D |
6,500 |
20,923 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-07 |
4 |
D |
$26.31 |
$122,184 |
D/D |
(4,644) |
264,246 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
officerTitle |
|
2007-03-02 |
4 |
D |
$26.42 |
$59,921 |
D/D |
(2,268) |
254,751 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-04 |
4 |
D |
$26.43 |
$99,430 |
D/D |
(3,762) |
265,622 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-06 |
4 |
D |
$26.43 |
$88,065 |
D/D |
(3,332) |
268,890 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2007-03-06 |
4/A |
D |
$27.01 |
$67,930 |
D/D |
(2,515) |
257,497 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2007-03-06 |
4/A |
A |
$27.01 |
$142,100 |
D/D |
5,261 |
260,012 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2007-03-06 |
4 |
D |
$27.01 |
$67,930 |
D/D |
(2,515) |
257,497 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2007-03-06 |
4 |
A |
$27.01 |
$142,100 |
D/D |
5,261 |
260,012 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2017-01-30 |
4 |
OE |
$27.01 |
$2,701,000 |
D/D |
100,000 |
957,931 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2010-09-20 |
4 |
D |
$27.81 |
$548,580 |
D/D |
(19,726) |
196,089 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2014-02-11 |
4 |
OE |
$28.11 |
$3,035,880 |
D/D |
108,000 |
586,562 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-05-04 |
4 |
D |
$28.71 |
$230,139 |
D/D |
(8,016) |
272,112 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2007-05-08 |
4 |
OE |
$28.90 |
$867,000 |
D/D |
30,000 |
287,497 |
0 |
- |
|
CTVA |
Corteva, Inc. |
Director |
|
2020-02-03 |
4 |
S |
$29.11 |
$2,620 |
D/D |
(90) |
14,348 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2007-05-08 |
4 |
D |
$30.21 |
$885,818 |
D/D |
(29,322) |
258,175 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2007-06-20 |
4 |
D |
$31.23 |
$57,619 |
D/D |
(1,845) |
256,330 |
0 |
- |
|
DWDP |
Dowdupont Inc. |
Director |
|
2019-05-21 |
4 |
B |
$31.99 |
$8,637 |
D/D |
270 |
22,231 |
2.39 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-06 |
4 |
D |
$32.33 |
$1,791,341 |
D/D |
(55,408) |
370,105 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-02 |
4 |
D |
$32.59 |
$355,101 |
D/D |
(10,896) |
306,919 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-03 |
4 |
D |
$32.59 |
$170,152 |
D/D |
(5,221) |
312,042 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-04 |
4 |
D |
$32.59 |
$122,604 |
D/D |
(3,762) |
315,733 |
0 |
- |
|
218 Records found
|
|
Page 5 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|